- Report
- March 2024
- 397 Pages
Global
From €7673EUR$7,950USD£6,582GBP
- Report
- September 2018
- 174 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- July 2019
- 498 Pages
Global
€21234EUR$22,000USD£18,215GBP
- Report
- April 2018
- 34 Pages
Global
From €9652EUR$10,000USD£8,279GBP
Saphris is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and depression. It is a type of atypical antipsychotic drug, which works by blocking certain receptors in the brain to reduce symptoms of mental illness. Saphris is available in tablet form and is taken orally. It is usually taken once or twice daily, depending on the patient's condition.
Saphris is manufactured by Merck & Co., Inc. and is available in the United States, Canada, and Europe. Other companies that produce similar medications include AstraZeneca, Eli Lilly, and Janssen Pharmaceuticals. These companies offer a variety of medications to treat mental disorders, including antipsychotics, antidepressants, and mood stabilizers.
The Saphris market is highly competitive, with many companies offering similar medications. Companies such as Merck & Co., AstraZeneca, Eli Lilly, and Janssen Pharmaceuticals are all major players in the market. Other companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals also offer medications for mental disorders. Show Less Read more